Sterol lipid metabolism in down syndrome revisited: Down syndrome is associated with a selective reduction in serum brassicasterol levels

Current Gerontology and Geriatrics Research

Volumn 2012, Issue , 2012, Pages

  Tansley, Gavin ^a   Holmes, Daniel T ^a   Lütjohann, Dieter ^b   Head, Elizabeth ^c   Wellington, Cheryl L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862285266     PISSN: 16877063     EISSN: 16877071     Source Type: Journal    
DOI: 10.1155/2012/179318     Document Type: Article

References (84)

1. Roizen N. J., Patterson D., Down's syndrome Lancet 2003 361 9365 1281 1289 (Pubitemid 36428586)
2. Nieuwenhuis-Mark R. E., Diagnosing alzheimer's dementia in down syndrome: problems and possible solutions Research in Developmental Disabilities 2009 30 5 827 838
3. Patterson D., Molecular genetic analysis of down syndrome Human Genetics 2009 126 1 195 214
4. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E., Alzheimer's disease the Lancet 2011 377 9770 1019 1031
5. Moore K. J., Tabas I., Macrophages in the pathogenesis of atherosclerosis Cell 2011 145 3 341 355
6. Murdoch J. C., Rodger J. C., Rao S. S., Down's syndrome: an atheroma free model? British Medical Journal 1977 2 6081 226 228 (Pubitemid 8144869)
7. Yl-Herttuala S., Luoma J., Nikkari T., Kivimaki T., Down's syndrome and atherosclerosis Atherosclerosis 1989 76 2-3 269 272 (Pubitemid 19101046)
8. Brattstrm L., Englund E., Brun A., Does down syndrome support homocysteine theory of arteriosclerosis? Lancet 1987 1 8529 391 392 (Pubitemid 17010060)
9. Draheim C. C., Geijer J. R., Dengel D. R., Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the down syndrome American Journal of Cardiology 2010 106 10 1512 1516
10. Beange H., McElduff A., Baker W., Medical disorders of adults with mental retardation: a population study American Journal on Mental Retardation 1995 99 6 595 604
11. Libby P., Ridker P. M., Hansson G. K., Progress and challenges in translating the biology of atherosclerosis Nature 2011 473 7347 317 325
12. Feinleib M., Kannel W. B., Garrison R. J., The framingham offspring study. design and preliminary data Preventive Medicine 1975 4 4 518 525
13. Goldstein J. L., Brown M. S., The ldl receptor Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 4 431 438
14. Brown M. S., Goldstein J. L., Lowering ldlnot only how low, but how long? Science 2006 311 5768 1721 1723
15. Alwaili K., Awan Z., Alshahrani A., Genest J., High-density lipoproteins and cardiovascular disease: 2010 update Expert Review of Cardiovascular Therapy 2010 8 3 413 423
16. Gordon T., Castelli W. P., Kannel W. B., Dawber T. R., High density lipoprotein as a protective factor against coronary heart disease American Journal of Medicine 1997 62 707 714
17. Tall A. R., Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins Journal of Internal Medicine 2008 263 3 256 273 (Pubitemid 351207349)
18. Cavelier C., Lorenzi I., Rohrer L., von Eckardstein A., Lipid efflux by the atp-binding cassette transporters abca1 and abcg1 Biochimica Et Biophysica Acta 2006 1761 7 655 666 (Pubitemid 44108746)
19. Lorkowski S., Rust S., Engel T., Jung E., Tegelkamp K., Galinski E. A., Assmann G., Cullen P., Genomic sequence and structure of the human ABCG1 (ABC8) gene Biochemical and Biophysical Research Communications 2001 280 1 121 131 (Pubitemid 32917486)
20. Li D., Zhang Y., Ma J., Ling W., Xia M., Adenosine monophosphate activated protein kinase regulates abcg1-mediated oxysterol efflux from endothelial cells and protects against hypercholesterolemia-induced endothelial dysfunction Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 7 1354 1362
21. Whetzel A. M., Sturek J. M., Nagelin M. H., ABCG1 deficiency in mice promotes endotehlial activation and monocyte-endothelial interactions Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 809 817
22. Patel M. D., Thompson P. D., Phytosterols and vascular disease Atherosclerosis 2006 186 1 12 19
23. Ntanios F. Y., Van De Kooij A. J., De Deckere E. A. M., Duchateau G. S. M. J. E., Trautwein E. A., Effects of various amounts of dietary plant sterol esters on plasma and hepatic sterol concentration and aortic foam cell formation of cholesterol-fed hamsters Atherosclerosis 2003 169 1 41 50 (Pubitemid 36830922)
24. Fassbender K., Lutjohann D., Dik M. G., Moderately elevated plant sterol levels are associated with reduced cardiovascular riskthe LASA study Atherosclerosis 2008 196 283 288
25. Salen G., Shefer S., Nguyen L., Ness G. C., Tint G. S., Shore V., Sitosterolemia Journal of Lipid Research 1992 33 7 945 957
26. Lu K., Lee M. H., Hazard S., Brooks-Wilson A., Hidaka H., Kojima H., Ose L., Stalenhoef A. F. H., Mietinnen T., Bjorkhem I., Bruckert E., Pandya A., Brewer H. B., Salen G., Dean M., Srivastava A., Patel S. B., Two genes that map to the stsl locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively American Journal of Human Genetics 2001 69 2 278 290 (Pubitemid 32695201)
27. Yu L., Hammer R. E., Li-Hawkins J., Von Bergmann K., Lutjohann D., Cohen J. C., Hobbs H. H., Disruption of abcg5 and abcg8 in mice reveals their crucial role in biliary cholesterol secretion Proceedings of the National Academy of Sciences of the United States of America 2002 99 25 16237 16242 (Pubitemid 35462779)
28. Sabeva N. S., McPhaul C. M., Li X., Cory T. J., Feola D. J., Graf G. A., Phytosterols differentially influence abc transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells Journal of Nutritional Biochemistry 2011 22 8 777 783
29. Licastro F., Marocchi A., Penco S., Porcellini E., Lio D., Dogliotti G., Corsi M. M., Does down's syndrome support the homocysteine theory of atherogenesis?. experience in elderly subjects with trisomy 21 Archives of Gerontology and Geriatrics 2006 43 3 381 387 (Pubitemid 44634131)
30. Braunschweig C. L., Gomez S., Sheean P., Tomey K. M., Rimmer J., Heller T., Nutritional status and risk factors for chronic disease in urban-dwelling adults with Down syndrome American Journal Of Mental Retardation 2004 109 186 193
31. Draheim C. C., McCubbin J. A., Williams D. P., Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome American Journal Of Mental Retardation 2002 107 201 211
32. Nishida Y., Akaoka I., Nishizawa T., Hyperlipidaemia in patients with down's syndrome Atherosclerosis 1977 26 3 369 372 (Pubitemid 8038230)
33. Dorner K., Gaethke A. S., Tolksdorf M., Cholesterol fractions and triglycerides in children and adults with down's syndrome Clinica Chimica Acta 1984 142 3 307 311 (Pubitemid 15223925)
34. Hardy J., Amyloid, the presenilins and alzheimer's disease Trends in Neurosciences 1997 20 4 154 159 (Pubitemid 27116286)
35. Nelson P. T., Braak H., Markesberry W. R., Neuropathology and cognitive impairment in Alzheimer's Disease: a complex but coherent relationship Journal of Neuropathology Experimental Neurology 2009 68 1 14
36. Sperling R. A., Aisen P. S., Beckett L. A., Bennett D. A., Craft S., Fagan A. M., Iwatsubo T., Jack C. R., Kaye J., Montine T. J., Park D. C., Reiman E. M., Rowe C. C., Siemers E., Stern Y., Yaffe K., Carrillo M. C., Thies B., Morrison-Bogorad M., Wagster M. V., Phelps C. H., Toward defining the preclinical stages of alzheimer's disease: recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for alzheimer's disease Alzheimer's and Dementia 2011 7 3 280 292
37. Epstein C. J., Scriver C. R., Beaudet A. L., Sly W. S., Valle D., Down Syndrome The Metabolic and Molecular Bases of Inherited Disease 2001 8th New York, NY, USA McGraw Hill 1223 1256
38. Arai Y., Suzuki A., Mizuguchi M., Takashima S., Developmental and aging changes in the expression of amyloid precursor protein in down syndrome brains Brain and Development 1997 19 4 290 294 (Pubitemid 27236856)
39. Argellati F., Massone S., D'Abramo C., Marinari U. M., Pronzato M. A., Domenicotti C., Ricciarelli R., Evidence against the overexpression of app in down syndrome IUBMB Life 2006 58 2 103 106
40. Gyure K. A., Durham R., Stewart W. F., Smialek J. E., Troncoso J. C., Intraneuronal a -amyloid precedes development of amyloid plaques in down syndrome Archives of Pathology and Laboratory Medicine 2001 125 4 489 492 (Pubitemid 32291552)
41. Mehta P. D., Dalton A. J., Mehta S. P., Kim K. S., Sersen E. A., Wisniewski H. M., Increased plasma amyloid protein 1-42 levels in down syndrome Neuroscience Letters 1998 241 1 13 16 (Pubitemid 28079022)
42. Runz H., Rietdorf J., Tomic I., De Bernard M., Beyreuther K., Pepperkok R., Hartmann T., Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells Journal of Neuroscience 2002 22 5 1679 1689 (Pubitemid 35386286)
43. Bodovitz S., Klein W. L., Cholesterol modulates -secretase cleavage of amyloid precursor protein Journal of Biological Chemistry 1996 271 8 4436 4440
44. Eckert G. P., Cairns N. J., Maras A., Gattaz W. F., Mller W. E., Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in alzheimer's disease Dementia and Geriatric Cognitive Disorders 2000 11 4 181 186 (Pubitemid 30416021)
45. Kojro E., Gimpl G., Lammich S., Mrz W., Fahrenholz F., Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the -secretase adam 10 Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5815 5820 (Pubitemid 32435725)
46. Jiang Q., Lee C. Y. D., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., Mann K., Lamb B., Willson T. M., Collins J. L., Richardson J. C., Smith J. D., Comery T. A., Riddell D., Holtzman D. M., Tontonoz P., Landreth G. E., Apoe promotes the proteolytic degradation of a Neuron 2008 58 5 681 693 (Pubitemid 351778466)
47. Mahley R. W., Rall S. C., Apolipoprotein e: far more than a lipid transport protein Annual Review of Genomics and Human Genetics 2000 1 2000 507 537
48. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A., Gene dose of apolipoprotein e type 4 allele and the risk of alzheimer's disease in late onset families Science 1993 261 5123 921 923 (Pubitemid 23275809)
49. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Rimmler J. B., Locke P. A., Conneally P. M., Schmader K. E., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A., Protective effect of apolipoprotein e type 2 allele for late onset alzheimer disease Nature Genetics 1994 7 2 180 184 (Pubitemid 24174658)
50. Finckh U., The future of genetic association studies in alzheimer disease Journal of Neural Transmission 2003 110 3 253 266 (Pubitemid 36359690)
51. Fan J., Donkin J., Wellington C., Greasing the wheels of a clearance in alzheimer's disease: the role of lipids and apolipoprotein E Biofactors 2009 35 3 239 248
52. Hirsch-Reinshagen V., Maia L. F., Burgess B. L., Blain J. F., Naus K. E., McIsaac S. A., Parkinson P. F., Chan J. Y., Tansley G. H., Hayden M. R., Poirier J., Van Nostrand W., Wellington C. L., The absence of ABCA1 decreases soluble apoe levels but does not diminish amyloid deposition in two murine models of alzheimer disease Journal of Biological Chemistry 2005 280 52 43243 43256 (Pubitemid 43049291)
53. Wahrle S. E., Jiang H., Parsadanian M., Hartman R. E., Bales K. R., Paul S. M., Holtzman D. M., Deletion of abca1 increases a deposition in the pdapp transgenic mouse model of alzheimer disease Journal of Biological Chemistry 2005 280 52 43236 43242 (Pubitemid 43049290)
54. Koldamova R., Staufenbiel M., Lefterov I., Lack of ABCA1 considerably decreases brain apoe level and increases amyloid deposition in APP23 mice Journal of Biological Chemistry 2005 280 52 43224 43235 (Pubitemid 43049289)
55. Wahrle S. E., Jiang H., Parsadanian M., Kim J., Li A., Knoten A., Jain S., Hirsch-Reinshagen V., Wellington C. L., Bales K. R., Paul S. M., Holtzman D. M., Overexpression of abca1 reduces amyloid deposition in the pdapp mouse model of alzheimer disease Journal of Clinical Investigation 2008 118 2 671 682 (Pubitemid 351206556)
56. Kivipelto M., Helkala E. L., Laakso M. P., Hnninen T., Hallikainen M., Alhainen K., Iivonen S., Mannermaa A., Tuomilehto J., Nissinen A., Soininen H., Apolipoprotein e 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life alzheimer disease Annals of Internal Medicine 2002 137 3 149 155 (Pubitemid 34827510)
57. Kivipelto M., Helkala E. L., Laakso M. P., Hnninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissien A., Midlife vascular risk factors and alzheimer's disease in later life: longitudinal, population based study BMJ 2001 322 7300 1447 1451 (Pubitemid 32575406)
58. Kivipelto M., Laakso M. P., Tuomilehto J., Nissinen A., Soininen H., Hypertension and hypercholesterolaemia as risk factors for alzheimer's disease: potential for pharmacological intervention CNS Drugs 2002 16 7 435 444 (Pubitemid 34729148)
59. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kreholt I., Winblad B., Helkala E. L., Tuomilehto J., Soininen H., Nissinen A., Obesity and vascular risk factors at midlife and the risk of dementia and alzheimer disease Archives of Neurology 2005 62 10 1556 1560 (Pubitemid 41434560)
60. Kivipelto M., Solomon A., Cholesterol as a risk factor for alzheimer's disease-epidemiological evidence Acta Neurologica Scandinavica 2006 114 185 50 57 (Pubitemid 44015225)
61. Dietschy J. M., Turley S. D., Cholesterol metabolism in the brain Current Opinion in Lipidology 2001 12 2 105 112 (Pubitemid 32242918)
62. Lewis T. L., Cao D., Lu H., Mans R. A., Su Y. R., Jungbauer L., Linton M. F., Fazio S., LaDu M. J., Li L., Overexpression of human apolipoprotein a-i preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of alzheimer disease Journal of Biological Chemistry 2010 285 47 36958 36968
63. Lefterov I., Fitz N. F., Cronican A. A., Fogg A., Lefterov P., Kodali R., Wetzel R., Koldamova R., Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1E9 mice Journal of Biological Chemistry 2010 285 47 36945 36957
64. Han X., Rozen S., Boyle S. H., Hellegers C., Cheng H., Burke J. R., Welsh-Bohmer K. A., Doraiswamy P. M., Kaddurah-Daouk R., Metabolomics in early alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics Plos One 2011 6 7
65. Jick H., Zornberg G. L., Jick S. S., Seshadri S., Drachman D. A., Statins and the risk of dementia Lancet 2000 356 9242 1627 1631
66. Wolozin B., Kellman W., Ruosseau P., Celesia G. G., Siegel G., Decreased prevalence of alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitors Archives of Neurology 2000 57 10 1439 1443
67. Wolozin B., Wang S. W., Li N. C., Lee A., Lee T. A., Kazis L. E., Simvastatin is associated with a reduced incidence of dementia and parkinson's disease BMC Medicine 2007 5, article no. 20
68. McGuinness B., Craig D., Bullock R., Passmore P., Statins for the prevention of dementia Cochrane Database of Systematic Reviews 2009 2
69. Sano M., Bell K. L., Galasko D., A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease Neurology 2011 77 556 563
70. Jack C. R. Jr., Vemuri P., Wiste H. J., Evidence for ordering of Alzheimer Disease biomarkers Archives of Neurology 2011 68 12 1526 1535
71. Vanmierlo T., Popp J., Kolsch H., The plant sterol brassicasterol as an additional CSF biomarker in Alzheimer's disease Acta Psychiatrica Scandinavica. Supplementum 2011 124 184 192
72. Teunissen C. E., De Vente J., Von Bergmann K., Bosma H., Van Boxtel M. P. J., De Bruijn C., Jolles J., Steinbusch H. W. M., Ltjohann D., Serum cholesterol, precursors and metabolites and cognitive performance in an aging population Neurobiology of Aging 2003 24 1 147 155 (Pubitemid 35454151)
73. Ltjohann D., Stroick M., Bertsch T., Khl S., Lindenthal B., Thelen K., Andersson U., Bjrkhem I., Von Bergmann K., Fassbender K., High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs Steroids 2004 69 6 431 438 (Pubitemid 38829339)
74. Bjorkhem I., Lutjohann D., Diczfalusy U., Stahle L., Ahlborg G., Wahren J., Cholesterol homeostasis in the human brain: turnover of 24S- hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation Journal of Lipid Research 1998 39 1594 1600 (Pubitemid 28377923)
75. Ltjohann D., Von Bergmann K., 24s-hydroxycholesterol: a marker of brain cholesterol metabolism Pharmacopsychiatry 2003 36, supplement 2 S102 S106
76. Chan RB, Oliveria TG, Cortes EP, Comparative lipidomic analysis of mouse and human brain with Alzheimer disease The Journal of Biological Chemistry 2011 287 2678 2688
77. Thomas A., Lenglet S., Chaurand P., Mass spectrometry for the evaluation of cardiovascular disease based on proteomics and lipidomics Thrombosis and Haemostasis 2011 106 20 33
78. Carr B. R., Rainey W. E., Mason J. I., 3-hydroxy-3-methylglutaryl coenzyme a reductase in anencephalic and normal human fetal liver Journal of Clinical Investigation 1985 76 5 1946 1949 (Pubitemid 16196068)
79. Bocconi L., Nava S., Fogliani R., Nicolini U., Trisomy 21 is associated with hypercholesterolemia during intrauterine life American Journal of Obstetrics and Gynecology 1997 176 3 540 543 (Pubitemid 27147158)
80. Diomede L., Salmona M., Albani D., Bianchi M., Bruno A., Salmona S., Nicolini U., Alteration of srebp activation in liver of trisomy 21 fetuses Biochemical and Biophysical Research Communications 1999 260 2 499 503 (Pubitemid 29352091)
81. Baldan A., Tarr P., Lee R., Edwards P. A., Atp-binding cassette transporter g1 and lipid homeostasis Current Opinion in Lipidology 2006 17 3 227 232 (Pubitemid 43786055)
82. Basso F., Amar M. J., Wagner E. M., Vaisman B., Paigen B., Santamarina-Fojo S., Remaley A. T., Enhanced ABCG1 expression increases atherosclerosis in LDLr-KO mice on a western diet Biochemical and Biophysical Research Communications 2006 351 2 398 404 (Pubitemid 44679753)
83. Ranalletta M., Wang N., Han S., Yvan-Charvet L., Welch C., Tall A. R., Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 10 2308 2315 (Pubitemid 44465727)
84. Burgess B., Naus K., Chan J., Overexpression of human ABCG1 does not affect atherosclerosis in fat-fed ApoE-deficient mice Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 1731 1737